Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28449038 | 1.00 | CYP3A4 (0.60) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL3685533 | 0.94 | CYP3A4 (0.57) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL8128069 | 0.94 | CYP3A4 (0.57) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL3677109 | 0.94 | CYP3A4 (0.57) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL16447750 | 0.91 | CYP3A4 (0.68) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL17889800 | 0.91 | CYP3A4 (0.68) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL27210 | 0.91 | CYP3A4 (0.72) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL10946403 | 0.89 | CYP3A4 (0.66) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL962909 | 0.89 | CYP3A4 (0.70) | CYP3A4TSHRTDP1ATMRECQL | |
| Hydrogen Sulfide SCHEMBL7193596 | 0.89 | CYP3A4 (0.70) | CYP3A4TSHRTDP1ATMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729526-A2 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | Galata Chemicals, LLC (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | GALATA CHEMICALS LLC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4229107-A1 | ONE-COMPONENT POLYURETHANE ADHESIVE | DDP Specialty Electronic Materials US, LLC (US) | 2023-08-23 | — | — | EP | claimed |
| EP-3774968-B1 | POLYURETHANE FOAM FORMING COMPOSITIONS | SOUDAL (BE) | 2022-08-17 | — | — | EP | claimed |
| WO-2022081251-A1 | ONE-COMPONENT POLYURETHANE ADHESIVE | DDP SPECIALTY ELECTRONIC MATERIALS US, LLC (US) | 2022-04-21 | — | — | WO | claimed |
| US-20210155740-A1 | POLYURETHANE FOAM FORMING COMPOSITIONS | SOUDAL (BE) | 2021-05-27 | — | — | US | claimed |
| EP-3774968-A1 | POLYURETHANE FOAM FORMING COMPOSITIONS | SOUDAL (BE) | 2021-02-17 | — | — | EP | claimed |
| WO-2019193178-A1 | POLYURETHANE FOAM FORMING COMPOSITIONS | SOUDAL (BE) | 2019-10-10 | — | — | WO | claimed |
| EP-3549967-A1 | POLYURETHANE FOAM FORMING COMPOSITIONS | SOUDAL (BE) | 2019-10-09 | — | — | EP | claimed |
| US-20120309924-A1 | Process for Preparing Amide Gellant Compounds with Aromatic End Groups | XEROX CORPORATION (US) | 2012-12-06 | — | — | US | claimed |
| US-20090227710-A1 | SILANE-TERMINATED POLYURETHANES WITH HIGH STRENGTH AND HIGH ELONGATION | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-09-10 | — | — | US | claimed |
| EP-1582541-A2 | Silane-Terminated Polyurethanes with high stregth and high elongation | Construction Research & Technology GmbH (DE) | 2005-10-05 | — | — | EP | claimed |
| US-20050215701-A1 | Silane-terminated polyurethanes with high strength and high elongation | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2005-09-29 | — | — | US | claimed |
| US-4518732-A | SULFUR-CONTAINING ORGANOTIN COMPOUND, SOLID WAX LUBRICANT, HALOGEN | CIBA GEIGY CORPORATION (US) | 1985-05-21 | — | — | US | claimed |
| WO-2026087277-A1 | FOAM STABILIZER FOR THE PRODUCTION OF POLYURETHANE FLEXIBLE FOAMS | EVONIK OPERATIONS GMBH (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4729526-A2 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | Galata Chemicals, LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4720149-A1 | AMINE CATALYSTS FOR POLYURETHANE APPLICATIONS | Evonik Operations GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-5334620-A | Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone | BASF AKTIENGESELLSCHAFT (DE) | 1994-08-02 | — | — | US | disclosed |
| US-5306798-A | Transparent, autoclavable, non-cytotoxic, essentially compact polyurethane embedding compositions, the preparation thereof and the use thereof, especially for articles used in medicine | BASF AKTIENGESELLSCHAFT (DE) | 1994-04-26 | — | — | US | disclosed |
| US-5254597-A | Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone | BASF A.G. (DE) | 1993-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | MGMT, TST, MPST | CYP3A4 1692/4885TSHR 199/4885TDP1 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.